InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
7
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Eisner Mark, VP Exécutif. Director active across 2 companies, notably Vir Biotechnology, Inc.. In total, 23 reports have been recorded. Split: 0 buy · 7 sells. Total volume traded: €426k. History available since 4 October 2021. The latest transaction was disclosed on 24 February 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Eisner Mark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations23 total
1,616 shares@ US$9.53260.0016% mcap50.0% of flowCommon StockSEC:0001628280-26-012394:0
55,000 shares0Common StockSEC:0001628280-26-011329:0
6,796 shares@ US$5.468271.0% of flowCommon StockSEC:0001628280-25-035269:0
40,000 shares0Common StockSEC:0001628280-25-007699:0
75,000 shares0Common StockSEC:0000950170-24-083951:0
1,860 shares@ US$0.96310.2% of flowCommon StockSEC:0001209191-23-048809:0
1,085 shares@ US$1.060.1% of flowCommon StockSEC:0001209191-23-048555:0
2,042 shares@ US$17.0383.7% of flowCommon StockSEC:0001209191-23-036054:0
1,090 shares@ US$18.832.2% of flowCommon StockSEC:0001209191-23-034288:0
9,182 shares@ US$18.783818.1% of flowCommon StockSEC:0001209191-23-023592:0
7,363 shares@ US$21.155917.0% of flowCommon StockSEC:0001209191-23-018063:0
1,187 shares@ US$21.872.8% of flowCommon StockSEC:0001209191-23-016362:0
32,500 shares0Common StockSEC:0001209191-23-012425:0
1,084 shares@ US$15.041.8% of flowCommon StockSEC:0001209191-22-059472:0
6,777 shares@ US$13.0110.3% of flowCommon StockSEC:0001209191-22-052381:0
756 shares@ US$13.091.1% of flowCommon StockSEC:0001209191-22-048555:0
1,141 shares@ US$9.612.8% of flowCommon StockSEC:0001209191-22-034041:0
6,442 shares@ US$12.0218.9% of flowCommon StockSEC:0001209191-22-022095:0
756 shares@ US$13.622.5% of flowCommon StockSEC:0001209191-22-015366:0
60,000 shares0Common StockSEC:0001209191-22-010452:0
7,043 shares@ US$14.8224.8% of flowCommon StockSEC:0001209191-22-001743:0
4,338 shares@ US$12.6513.1% of flowCommon StockSEC:0001209191-21-067780:0
74,520 shares0Common StockSEC:0001209191-21-059869:0
23 of 23 declarations
About Eisner Mark
Eisner Mark is VP Exécutif, with listed roles at FIBROGEN INC, EVP, Chief Medical Officer, and at Vir Biotechnology, Inc., EVP and Chief Medical Officer. He has 23 filings in total, and across the sampled recent filings from 2021-10-06 to 2026-02-26, sales total 425980 EUR and the most common transaction nature is Retenue fiscale.
